Labcorp

The answers you need are within reach. Join us at ACR Convergence 2025 and visit booth 751 to meet our rheumatology team. Get the guidance you need to inform care decisions with the industry’s broadest portfolio for autoimmune conditions, backed by over 50 years of scientific leadership. Choose Labcorp Autoimmune: https://bit.ly/42IA56c #rheumatology #autoimmune #ACR25

Integrating diagnostics, clinical outcomes, and genomics can transform how diseases are understood and treated. Labcorp Real World Data is powering this shift with one of the world’s largest and most trusted datasets—delivering regulatory-grade insights that accelerate research and enable smarter, faster development decisions. Learn more: https://bit.ly/3WH1e60 #RealWorldData #EvidenceGeneration #BiopharmaInnovation

Baby Kaya touched the hearts of everyone she met. Genetic testing gave her family answers about her rare disease, and through the Kaya Girl Foundation, her legacy continues to empower families, raise awareness about genetic health, and advocate for re-testing as science advances. Discover her story and its impact:https://bit.ly/42HdG9q

When it comes to rare disease, clear genetic insights can help providers deliver personalized care to their patients. Join us at #ASHG25 for an education session where we'll share how, through our partnership with Alexion, we've combined variant knowledge datasets to help expand diagnostic and therapeutic options for patients.

It is #CustomerWeek2025 and we’re celebrating the shared commitment that drives everything we do at Labcorp. This year’s theme, Mission Possible, reflects how we turn challenges into opportunities through collaboration, innovation and dedication. Whether supporting diagnostics, advancing trials or fueling research, every contribution helps improve health and improve lives.

Congrats to Roche on the FDA clearance of pTau-181, a blood-based test for Alzheimer’s disease. This marks the second approval this year of a blood-based test to aid in the assessment of patients being evaluated for Alzheimer's disease and the first test to be cleared for use in primary care. Standardizing tests like pTau-181 enables earlier, more precise insights for patients and care teams. Labcorp is proud to support this success in bringing clarity to complex questions. Learn more: https://bit.ly/43iDN6F

Early gaps in care intervention combined with proactive communication can help to exponentially reduce chronic disease costs and improve health outcomes. Find out how to increase member engagement and create healthier communities: https://bit.ly/4h2XlBI

Knowledge is power when it comes to hereditary cancer risk. Labcorp’s genetic testing identifies changes in genes like 𝐵𝑅𝐶𝐴1 and 𝐵𝑅𝐶𝐴2 that may increase cancer risk. These insights can guide early screening, enable personalized care, and give families peace of mind. Watch our webinar with Dr. Heidi Ko to learn more: https://bit.ly/4nPC3dE

Menopause brings changes. Knowing what’s happening in your body can help you feel supported and confident. Learn how to spot the signs and support your health: https://bit.ly/4nGARcr

Physicians spend an average of 13 hours a week on indirect patient care, including EHR tasks. This burden drives burnout and takes time away from patients. Labcorp’s Test Finder uses generative AI to provide fast, intuitive, and contextual access to lab test information, making complex healthcare data easier to navigate. Learn more in Dr. Brian Caveney’s Q&A with Physician's Weekly: https://bit.ly/4mOz4k8 #HealthcareInnovation #LabcorpTestFinder #GenerativeAI